HWM
HAE icon

Hemington Wealth Management’s Haemonetics HAE Stock Holding History

Hemington Wealth Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$0 Sell
9
-50
-85% -$3.1K ﹤0.01% 1610
2025
Q2 		$4K Buy
59
+7
+13% +$463 ﹤0.01% 1156
2025
Q1 		$3K Buy
52
+28
+117% +$1.9K ﹤0.01% 1191
2024
Q4 		$1K Buy
24
+9
+60% +$723 ﹤0.01% 1402
2024
Q3 		$1K Buy
+15
New +$1.21K ﹤0.01% 1324

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hemington Wealth Management's HAE Position: Q3 2025 in Review

Hemington Wealth Management reduced its Haemonetics (HAE) stake by 85% in Q3 2025, selling an estimated $3.1K and leaving 9 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1610.

Hemington Wealth Management first reported a position in HAE in Q3 2024 and has held it in 5 quarters since. The position peaked at $4K in Q2 2025. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Hemington Wealth Management held 9 shares of Haemonetics worth $0 as of Q3 2025.
  • Hemington Wealth Management sold 50 Haemonetics shares in Q3 2025, an estimated $3.1K.
  • Haemonetics made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1610 holding.
  • Hemington Wealth Management first reported a position in Haemonetics in Q3 2024 and has held it in 5 quarters since.
  • Hemington Wealth Management's Haemonetics position peaked at $4K in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.